BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S, Treig J, Schulz-schaeffer W, Cramm M, Schmitz M, Zerr I. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology 2018;91:e331-8. [DOI: 10.1212/wnl.0000000000005860] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Bernardini A, Gigli GL, Janes F, Pellitteri G, Ciardi C, Fabris M, Valente M. Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report. Prion 2022;16:78-83. [PMID: 35786166 DOI: 10.1080/19336896.2022.2095185] [Reference Citation Analysis]
2 Shir D, Lazar EB, Graff-Radford J, Aksamit AJ, Cutsforth-Gregory JK, Jones DT, Botha H, Ramanan VK, Prusinski C, Porter A, Day GS. Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021. JAMA Netw Open 2022;5:e2225098. [PMID: 35921110 DOI: 10.1001/jamanetworkopen.2022.25098] [Reference Citation Analysis]
3 Fearon C, Howley R, Looby S, Byrne A, Heffernan J, Heeney C, Beausang A, Cryan J, Farrell M, O'Dowd S, Brett F. Establishing a committee for antemortem reviews of suspect Creutzfeldt-Jakob disease cases in Ireland. Ir J Med Sci 2022. [PMID: 35840825 DOI: 10.1007/s11845-022-03070-2] [Reference Citation Analysis]
4 Na S, Lee SA, Lee JD, Lee ES, Lee TK. Creutzfeldt-Jakob disease presenting with bilateral hearing loss: A case report. World J Clin Cases 2022; 10(18): 6333-6337 [DOI: 10.12998/wjcc.v10.i18.6333] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Day GS. Rapidly Progressive Dementia. Continuum (Minneap Minn) 2022;28:901-36. [PMID: 35678409 DOI: 10.1212/CON.0000000000001089] [Reference Citation Analysis]
6 Hermann P, Zerr I. Rapidly progressive dementias - aetiologies, diagnosis and management. Nat Rev Neurol 2022. [PMID: 35508635 DOI: 10.1038/s41582-022-00659-0] [Reference Citation Analysis]
7 Poleggi A, Baiardi S, Ladogana A, Parchi P. The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases. Front Aging Neurosci 2022;14:874734. [DOI: 10.3389/fnagi.2022.874734] [Reference Citation Analysis]
8 Schmitz M, Villar-Piqué A, Hermann P, Escaramís G, Calero M, Chen C, Kruse N, Cramm M, Golanska E, Sikorska B, Liberski PP, Pocchiari M, Lange P, Stehmann C, Sarros S, Martí E, Baldeiras I, Santana I, Žáková D, Mitrová E, Dong XP, Collins S, Poleggi A, Ladogana A, Mollenhauer B, Kovacs GG, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain 2022:awab350. [PMID: 35288744 DOI: 10.1093/brain/awab350] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Vascellari S, Orrù CD, Caughey B. Real-Time Quaking- Induced Conversion Assays for Prion Diseases, Synucleinopathies, and Tauopathies. Front Aging Neurosci 2022;14:853050. [DOI: 10.3389/fnagi.2022.853050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Watson N, Hermann P, Ladogana A, Denouel A, Baiardi S, Colaizzo E, Giaccone G, Glatzel M, Green AJE, Haïk S, Imperiale D, MacKenzie J, Moda F, Smith C, Summers D, Tiple D, Vaianella L, Zanusso G, Pocchiari M, Zerr I, Parchi P, Brandel JP, Pal S. Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease. JAMA Netw Open 2022;5:e2146319. [PMID: 35099544 DOI: 10.1001/jamanetworkopen.2021.46319] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW. Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener 2021;16:83. [PMID: 34922583 DOI: 10.1186/s13024-021-00501-z] [Reference Citation Analysis]
12 Wu J, Chen D, Shi Q, Dong X. Protein amplification technology: New advances in human prion disease diagnosis. Biosafety and Health 2021;3:325-32. [DOI: 10.1016/j.bsheal.2021.09.003] [Reference Citation Analysis]
13 Beretta S, Stabile A, Balducci C, DiFrancesco JC, Patruno A, Rona R, Bombino M, Capraro C, Andreetta F, Cavalcante P, Moda F, Citerio G, Foti G, Bogliun G, Ferrarese C. COVID-19-associated immune-mediated encephalitis mimicking acute-onset Creutzfeldt-Jakob disease. Ann Clin Transl Neurol 2021;8:2314-8. [PMID: 34825771 DOI: 10.1002/acn3.51479] [Reference Citation Analysis]
14 Feng S, Zhao X, Zhou X, Ye X, Yu X, Jiang W, Deng Y, Zhou S, Ma L, Shan P, Zhou G. Epidemiological and Clinical Characteristics of Sporadic Creutzfeldt-Jakob Disease: A Retrospective Study in Eastern China. Front Neurol 2021;12:700485. [PMID: 34690910 DOI: 10.3389/fneur.2021.700485] [Reference Citation Analysis]
15 Cazzaniga FA, Bistaffa E, De Luca CMG, Bufano G, Indaco A, Giaccone G, Moda F. Sporadic Creutzfeldt-Jakob disease: Real-Time Quaking Induced Conversion (RT-QuIC) assay represents a major diagnostic advance. Eur J Histochem 2021;65. [PMID: 34657408 DOI: 10.4081/ejh.2021.3298] [Reference Citation Analysis]
16 Luk CC, Mathiason CK, Orrù CD, Jansen GH, Thiele A, Caughey B, Sim VL. Creutzfeldt-Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues. Prion 2021;15:107-11. [PMID: 34132175 DOI: 10.1080/19336896.2021.1933872] [Reference Citation Analysis]
17 Diaz-Lucena D, Kruse N, Thüne K, Schmitz M, Villar-Piqué A, da Cunha JEG, Hermann P, López-Pérez Ó, Andrés-Benito P, Ladogana A, Calero M, Vidal E, Riggert J, Pineau H, Sim V, Zetterberg H, Blennow K, Del Río JA, Marín-Moreno A, Espinosa JC, Torres JM, Sánchez-Valle R, Mollenhauer B, Ferrer I, Zerr I, Llorens F. TREM2 expression in the brain and biological fluids in prion diseases. Acta Neuropathol 2021;141:841-59. [PMID: 33881612 DOI: 10.1007/s00401-021-02296-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 Watson N, Brandel JP, Green A, Hermann P, Ladogana A, Lindsay T, Mackenzie J, Pocchiari M, Smith C, Zerr I, Pal S. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol 2021;17:362-79. [PMID: 33972773 DOI: 10.1038/s41582-021-00488-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Solje E, Benussi A, Buratti E, Remes AM, Haapasalo A, Borroni B. State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia-A Short Review and Diagnostic Algorithm. Diagnostics (Basel) 2021;11:788. [PMID: 33925655 DOI: 10.3390/diagnostics11050788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zerr I, Villar-Piqué A, Hermann P, Schmitz M, Varges D, Ferrer I, Riggert J, Zetterberg H, Blennow K, Llorens F. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease. Alzheimers Res Ther 2021;13:86. [PMID: 33883011 DOI: 10.1186/s13195-021-00815-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Dong TT, Satoh K. The Latest Research on RT-QuIC Assays-A Literature Review. Pathogens 2021;10:305. [PMID: 33807776 DOI: 10.3390/pathogens10030305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
22 Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, Green A, Haïk S, Kovacs GG, Ladogana A, Llorens F, Mead S, Nishida N, Pal S, Parchi P, Pocchiari M, Satoh K, Zanusso G, Zerr I. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 2021;20:235-46. [PMID: 33609480 DOI: 10.1016/S1474-4422(20)30477-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
23 Xu Z, Zhao Y. A Creutzfeldt-Jakob disease case misdiagnosed with acute cerebral infarction and review of the literature. Clin Case Rep 2020;8:3311-5. [PMID: 33363924 DOI: 10.1002/ccr3.3388] [Reference Citation Analysis]
24 Zerr I, Cramm M, da Silva Correia SM, Zafar S, Villar-Piqué A, Llorens F, Schmitz M. Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis. Front Bioeng Biotechnol 2020;8:586890. [PMID: 33330419 DOI: 10.3389/fbioe.2020.586890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ascari LM, Rocha SC, Gonçalves PB, Vieira TCRG, Cordeiro Y. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies. Front Bioeng Biotechnol 2020;8:585896. [PMID: 33195151 DOI: 10.3389/fbioe.2020.585896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 McCollum L, Karlawish J. Cognitive Impairment Evaluation and Management. Med Clin North Am 2020;104:807-25. [PMID: 32773047 DOI: 10.1016/j.mcna.2020.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Hermann P, Treig J, Unkel S, Goebel S, Bunck T, Jünemann M, Friede T, Zerr I. Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993-2018. Emerg Infect Dis 2020;26. [PMID: 32687038 DOI: 10.3201/eid2608.191159] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Koutsouraki E, Michmizos D, Patsi O, Tzartos J, Spilioti M, Arnaoutoglou M, Tsolaki M. A probable role of copper in the comorbidity in Wilson's and Creutzfeldt-Jakob's Diseases: a case report. Virol J 2020;17:35. [PMID: 32169096 DOI: 10.1186/s12985-020-01309-x] [Reference Citation Analysis]
29 Llorens F, Villar-Piqué A, Hermann P, Schmitz M, Calero O, Stehmann C, Sarros S, Moda F, Ferrer I, Poleggi A, Pocchiari M, Catania M, Klotz S, O'Regan C, Brett F, Heffernan J, Ladogana A, Collins SJ, Calero M, Kovacs GG, Zerr I. Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease. Biomolecules 2020;10:E290. [PMID: 32059611 DOI: 10.3390/biom10020290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Minikel EV, Kuhn E, Cocco AR, Vallabh SM, Hartigan CR, Reidenbach AG, Safar JG, Raymond GJ, McCarthy MD, O'Keefe R, Llorens F, Zerr I, Capellari S, Parchi P, Schreiber SL, Carr SA. Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry. Mol Cell Proteomics 2019;18:2388-400. [PMID: 31558565 DOI: 10.1074/mcp.RA119.001702] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
31 Navid J, Day GS, Strain J, Perrin RJ, Bucelli RC, Dincer A, Wisch JK, Soleimani-Meigooni D, Morris JC, Benzinger TLS, Ances BM. Structural signature of sporadic Creutzfeldt-Jakob disease. Eur J Neurol 2019;26:1037-43. [PMID: 30735286 DOI: 10.1111/ene.13930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Krüger S, Larsen J, Schaumberg J. [Sporadic Creutzfeldt-Jakob disease imitates posterior reversible encephalopathy syndrome]. Nervenarzt 2019;90:618-22. [PMID: 30840102 DOI: 10.1007/s00115-019-0679-5] [Reference Citation Analysis]
33 Green AJE. RT-QuIC: a new test for sporadic CJD. Pract Neurol 2019;19:49-55. [PMID: 30282760 DOI: 10.1136/practneurol-2018-001935] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]